Tag Archives: David Koepsell

David Koepsell: nanotechnology brings the intellectual property regime to an end

David Koepsell, author of Innovation and Nanotechnology: Converging Technologies and the End of Intellectual Property, is a philosopher, attorney, and educator who teaches at the Delft University of Technology (the Netherlands). He is also author of Who Owns You? The Corporate Gold Rush to Patent Your Genes.

In a Feb. 27, 2012 interview with Dr. J (James Hughes, executive director of the Institute of Ethics for Emerging Technologies [IEET] and producer/interviewer for Changesurfer radio), Koepsell discussed his book about nanotechnology and the disappearance of intellectual property regimes in a 28 min. 51 sec. podcast.

Koepsell and Dr. J provided a good description of converging technologies so I’m going to plunge in without much introduction.

I wasn’t expecting to hear about Marxism and the means of production but there it was, mentioned in the context of a near future society where manufacturing can be done by anyone, anywhere by means of molecular manufacturing or by means of 3D fabrication, or etc. The notion is that production will be democratized as will the intellectual property regime. There were several mentions of the state (government) no longer having control in the future over intellectual property, specifically patents and copyrights, and some discussion of companies that guard their intellectual property jealously. (I have commented on the intellectual property topic, most recently,  in my Patents as weapons and obstacles posting in October 2011. Koepsell is mentioned in this posting.)

Both Koepsell and the interviewer (Dr. J) mentioned the possibility of widespread economic difficulty as jobs disappear due to the disappearance of manufacturing and other associated jobs as people can produce their own goods (much like you can with Star Trek’s replicators). But it did seem they mentioned job loss somewhat blithely, secure in their own careers as academics who as a group are not known for their manufacturing prowess or, for that matter, the production of any goods whatsoever.

It seems to me this future bears a remarkable resemblance to the past, where people had to create their own products by raising their own food, spinning, weaving, and sewing their own clothes, etc. The Industrial Revolution changed all that and turned most folks into ‘wage slaves’. As I recall, that’s from Marx and it’s a description of a loss of personal agency/autonomy, i.e., being a slave to wages (no longer producing your own food, clothing, etc.) and not a reference to poor wages as many believe (including me until I got a somewhat snotty professor for one of my courses).

The podcast is definitely worth your time if you don’t mind the references to Marx (there aren’t many) as the ideas are provocative even if you don’t agree. Koepsell describes how his interest in this area was awakened (he wrote about software, which is both copyrightable as writing and patentable as a machine).

The book is available as a free download or you can purchase it here. Here’s a brief excerpt from the book’s introduction (I removed a citation number),

Science demands unfettered inquiry into the workings of nature, and replaces the confidence previously demanded over rote knowledge with a practiced skepticism, and ongoing investigation. With the rise of the age of science came the need to develop new means of treating information. Scientific investigations conducted by ‘natural philosophers’ could only be conducted in full view, out in the open, with results published in meetings of scientific societies and their journals. Supplanting secret-keeping and obscurantism, the full sunlight of public and peer scrutiny could begin to continually cleanse false assumptions and beliefs, and help to perfect theories about the workings of the world. Science demanded disclosure, where trades and arts often encouraged secrets. And so as natural philosophers began to disseminate the results of their investigations into nature, new forms of trade, art, and industry began to emerge, as well as the demand for new means of protection in the absence of secrecy. Thus, as the scientific age was dawning, and helping to fuel a new technological revolution, modern forms of IP [intellectual property] protection such as patents and copyrights emerged as states sought to encourage the development of the aesthetic and useful arts. By granting to authors and inventors a monopoly over the practice of their art, as long as they brought forth new and useful inventions (or for artistic works, as long as they were new), nation states helped to attract productive and inventive artisans and trades into their borders. These forms of state monopoly also enabled further centralization of trades and industries, as technologies now could become immune from the possibility of ‘reverse-engineering’ and competitors could be kept at bay by the force of law. This sort of state-sanctioned centralization and monopoly helped build the industrial revolution (by the account of many historians and economists, although this assumption has lately been challenged) as investors now could commodify new technologies free from the threat of direct competition, secure in the safe harbor of a state-supported monopoly over the practice of a useful art for a period of time.

In many ways, traditional IP [intellectual property] was (and is) deemed vital to the development of large industries and their infrastructures, and to the centralized, assembly-line factory mode of production that dominated the twentieth century. With the benefit of a state-sanctioned monopoly, industry could build sufficient infrastructure to dominate a market with a new technology for the duration of a patent. This confidence assured investors that there would be some period of return on the investment in which other potential competitors are held at bay, at least from practicing the art as claimed in the patent. Factories could be built, supply chains developed, and a market captured and profited from, and prices will not be subject to the ruthless dictates of supply and demand. Rather, because of the luxury of a protected market during the period of protection, innovators can inflate prices to not only recoup the costs of investment, but also profit as handsomely as the captive market will allow.

For most of the twentieth century, IP allowed the concentration of industrial production into the familiar factory, assembly-line model. Even while the knowledge behind new innovation moved eventually into the public domain as patents lapsed, during the course of the term of patent protection, strictly monopolized manufacturing processes and their products could be heavily capitalized, and substantial profits realized, before a technique or technology lost its protection. But the modes and methods of manufacturing are now changing, and the necessity of infrastructural investment is also being altered by the emergence of new means of production, including what we’ll call ‘micromanufacturing’, which is a transitional technology on the way to true MNT (molecular nanotechnology), and is included in our discussions of ‘nanowares’. Essentially, assembly-lines and supply chains that supported the huge monopolistic market dominance models of the industrial revolution, well into the twentieth century, are becoming obsolete. If innovation and production can be linked together with modern and futuristic breakthroughs in micromanufacturing (in which small components can be fabricated and produced en mass, cheaply) and eventually molecular manufacturing (in which items are built on the spot, from the ground up, molecule by molecule), then we should consider whether the IP regimes that helped fuel the industrial revolution are still necessary, or even whether they were ever necessary at all. Do they promote new forms of innovation and production, or might they instead stifle potentially revolutionary changes in our manners of creation and distribution?

Amusingly, towards the end of the interview Dr. J plugs Koepsell’s ‘nanotechnology’ book by noting it’s available for free downloads then saying ‘we’re hoping you’ll buy it’ (at the publisher’s site).

Patents as weapons and obstacles

I’m going to start with the phones and finish with the genes. The news article titled Patents emerge as significant tech strategy by Janet I. Tu featured Oct. 27, 2011 on physorg.com provides some insight into problems with  phones and patents,

It seems not a week goes by these days without news of another patent battle or announcement: Microsoft reaching licensing agreements with various device manufacturers. Apple and various handset manufacturers filing suits and countersuits. Oracle suing Google over the use of Java in Android.

After Microsoft and Samsung announced a patent-licensing agreement last month involving Google’s Android operating system, Google issued a statement saying, in part: “This is the same tactic we’ve seen time and again from Microsoft. Failing to succeed in the smartphone market, they are resorting to legal measures to extort profit from others’ achievements and hinder the pace of innovation.”

Microsoft’s PR chief Frank Shaw shot back via Twitter: “Let me boil down the Google statement … from 48 words to 1: Waaaah.”

This was Microsoft’s PR chief??? I do find this to be impressive,but not in a good way. Note: Tu’s article was originally published in The Seattle Times. [Dec.17.11: I’ve edited my original sentence to make the meaning clearer, i. e., I changed it from ‘I don’t find this to be impressive …]

My Sept. 27, 2011 posting focused on the OECD (Organization for Economic Cooperation and Development) and their Science Technology and Industry 2011 Scorecard where they specifically name patenting practices as a worldwide problem for innovation. As both the scorecard and Tu note (from the Tu article),

… technology companies’ patent practices have evolved from using them to defend their own inventions to deploying them as a significant part of competitive strategies …

Tu notes,

Microsoft says it’s trying to protect its investment in research and development – an investment resulting in some 32,000 current and 36,500 pending patents. [emphasis mine] It consistently ranks among the top three computer-software patent holders in the U.S.

One reason these patent issues are being negotiated now is because smartphones are computing devices with features that “are generally in the sweet spot of the innovations investments Microsoft has made in the past 20 years,” said Microsoft Deputy General Counsel Horacio Gutierrez.

There’s no arguing Microsoft is gaining a lot strategically from its patents: financially, legally and competitively.

Royalties from Android phones have become a fairly significant revenue stream.

Investment firm Goldman Sachs has estimated that, based on royalties of $3 to $6 per device, Microsoft will get about $444 million in fiscal year 2012 from Android-based device makers with whom it has negotiated agreements.

Some think that estimate may be low.

Microsoft is not disclosing how much it gets in royalties, but Smith, the company’s attorney, has said $5 per device “seems like a fair price.”

Various tech companies wield patents also to slow down competitors or to frustrate, and sometimes stop, a rival from entering a market. [emphases mine]

It’s not just one industry sector either. Another major player in this ‘patenting innovation to death game’ is the health care industry. Mike Masnick in his Oct. 28, 2011 Techdirt posting (Deadly Monopolies: New Book Explores How Patenting Genes Has Made Us Less Healthy) notes,

A few years ago, David Koepsell, came out with the excellent book, Who Owns You?, with the subtitle, “The corporate gold rush to patent your genes.” It looks like there’s now a new book [Deadly Monopolies] out exploring the same subject, by medical ethicist Harriet Washington.

NPR (National Public Radio) highlights this story in their feature on  Washington’s book,

Restrictive patents on genes prevent competition that can keep the medical cost of treatment down, says Washington. In addition to genes, she also points to tissue samples, which are also being patented — sometimes without patients’ detailed knowledge and consent. Washington details one landmark case in California in which medically valuable tissue samples from a patient’s spleen were patented by a physician overseeing his treatment for hairy-cell leukemia. The physician then established a laboratory to determine whether tissue samples could be used to create various drugs without informing the patient.

“[The patient] was told that he had to come to [the physician’s] lab for tests … in the name of vigilance to treat his cancer and keep him healthy,” says Washington.

The patient, a man named John Moore, was never told that his discarded body parts could be used in other ways. He sued his doctor and the University of California, where the procedure took place, for lying to him about his tissue — and because he did not want to be the subject of a patent. The case went all the way to the California Supreme Court, where Moore lost. In the decision, the court noted that Moore had no right to any share of the profits obtained from anything developed from his discarded body parts.

According to the webpage featuring Deadly Monopolies on the NPR website, this state of affairs is due to a US Supreme Court ruling made in 1980 where the court ruled,

… living, human-made microorganisms could be patented by their developers. The ruling opened the gateway for cells, tissues, genetically modified plants and animals, and genes to be patented.

I gather the US Supreme Court is currently reconsidering their stance on patents and genes. (As for Canada, we didn’t take that route with the consequence that it is not possible to patent a gene or tissue culture here. Of course, things could change.)

Open Science Summit nears

The July 29 -31, 2010 Open Science Summit is almost upon us (first mentioned here in a June 29, 3010 posting). The summit organizers pose this notion to set the themes for their conference (from the summit’s home page),

Renowned physicist Freeman Dyson identifies two kinds of scientific revolutions, those driven by new concepts (theoretical), and those driven by new tools (technological).

In the last 500 years we’ve witnessed paradigm shattering conceptual shifts associated with names such as Copernicus, Newton, Darwin, and, Einstein. Simultaneously, the evolution of technology drives progress in unpredictable ways—Galileo borrowed principles from the technology of eye-glasses to pioneer the use of the telescope in astronomy, while Watson and Crick relied on Rosalind Franklin’s skill with X-ray diffraction (a tool from physics) to probe the structure of life. (Undoubtedly, Franklin’s contribution would have been more fully recognized under a true Open Science Paradigm.)

To this classification of scientific revolutions, we can now add a third kind, an Organizational Revolution, the advent of a truly “Open Science,” which will profoundly affect the pace and character of subsequent theory and tool-driven paradigm shifts.

Looking at the speakers scheduled, the summit offers an interesting range including Christine Peterson of the Foresight Institute, Special Agent Edward You of the US Federal Bureau of Investigation (FBI)*, Michael Eisen, co-founder of the Public Library of Science (PLoS), David Koepsell, author of Who Owns You?, and more. It does seem to be largely oriented to genomics, bioinformatics, and other biological sciences.

If you can’t attend in person, there will be live streaming by fora.tv, go here.

* The FBI is quite interested in reaching out to scientists as per my posting of  May 25, 2010 about an article in The Scientist titled, SYNTHETIC BIO MEET “Fbio”; You may soon be visited by an FBI agent, or a scientist acting on behalf of one. Here’s why and written by Jill Frommer. The article is now behind a paywall.